EBOS Group Ltd
OTC:EBOSY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (3.8), the stock would be worth $35.13 (33% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.8 | $26.42 |
0%
|
| 3-Year Average | 3.8 | $35.13 |
+33%
|
| 5-Year Average | 3.8 | $35.31 |
+34%
|
| Industry Average | 3.3 | $30.28 |
+15%
|
| Country Average | 2.7 | $24.82 |
-6%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
5.4B USD | 2.8 | 34.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | -79.2 | 23.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.4B USD | 31.7 | 37.2 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.3B USD | 31.8 | 37.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.8B USD | -16.7 | 29.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.9B AUD | 6.4 | 34.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61.9B CNY | 0.8 | 10.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 2.7 | 22.3 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60B CNY | 2.5 | 21.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.7B HKD | 0.6 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
EBOS Group Ltd
Glance View
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. The company sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.
